PDL BioPharma, Inc. Research and Development Expense
PDL BioPharma, Inc. reported Research and Development Expense of $4.37 million for the 8-month period ending 2020-08-31, per its 10-K filed 2021-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2021-03-29
- PDL BioPharma, Inc. research and development expense for the quarter ending 2020-06-30 was $1.47M, a 65.35% increase year-over-year.
- PDL BioPharma, Inc. research and development expense for the quarter ending 2020-03-31 was $1.86M, a 103.96% increase year-over-year.
- PDL BioPharma, Inc. research and development expense for the quarter ending 2019-12-31 was $1.24M, a 103.93% increase year-over-year.
- PDL BioPharma, Inc. research and development expense for the quarter ending 2019-09-30 was $4.31M, a 541.37% increase year-over-year.
- PDL BioPharma, Inc. research and development expense for fiscal 2019 was $7.35M, a 166.40% increase from fiscal 2018.
- PDL BioPharma, Inc. research and development expense for fiscal 2018 was $2.76M.
- PDL BioPharma, Inc. research and development expense for fiscal 2016 was $3.82M.
- PDL BioPharma, Inc. research and development expense for fiscal 2015 was $0.00.
| Period end | Research and Development Expense 2 month | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 8 month | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-08-31 | $1.05M 10-Q · filed 2020-11-13 | $4.37M 10-K · filed 2021-03-29 | ||||||||
| 2020-06-30 | $1.47M 10-Q · filed 2020-08-07 | $3.32M 10-Q · filed 2020-08-07 | $4.57M derived: sum of 3 quarters · filed 2021-03-29 | $8.88M derived: sum of 4 quarters · filed 2021-03-29 | ||||||
| 2020-03-31 | $1.86M 10-Q · filed 2020-05-11 | $3.10M derived: sum of 2 quarters · filed 2021-03-29 | $7.41M derived: sum of 3 quarters · filed 2021-03-29 | $8.30M derived: sum of 4 quarters · filed 2021-03-29 | ||||||
| 2019-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $5.55M derived: sum of 2 quarters · filed 2021-03-29 | $6.44M derived: sum of 3 quarters · filed 2021-03-29 | $7.35M 10-K · filed 2021-03-29 | $7.31M 10-K · filed 2020-03-11 | |||||
| 2019-09-30 | $4.31M 10-Q · filed 2020-11-13 | $5.20M derived: sum of 2 quarters · filed 2020-11-13 | $6.11M 10-Q · filed 2020-11-13 | $6.07M 10-Q · filed 2019-11-06 | $6.72M derived: sum of 4 quarters · filed 2021-03-29 | |||||
| 2019-06-30 | $886.00K 10-Q · filed 2020-08-07 | $1.80M 10-Q · filed 2020-08-07 | $1.75M 10-Q · filed 2019-08-07 | $2.41M derived: sum of 3 quarters · filed 2021-03-29 | $3.08M derived: sum of 4 quarters · filed 2021-03-29 | |||||
| 2019-03-31 | $910.00K 10-Q · filed 2020-05-11 | $869.00K 10-Q · filed 2019-05-09 | $1.52M derived: sum of 2 quarters · filed 2021-03-29 | $2.19M derived: sum of 3 quarters · filed 2021-03-29 | $2.88M derived: sum of 4 quarters · filed 2021-03-29 | |||||
| 2018-12-31 | $610.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $1.28M derived: sum of 2 quarters · filed 2021-03-29 | $1.97M derived: sum of 3 quarters · filed 2021-03-29 | $2.76M 10-K · filed 2021-03-29 | $2.96M 10-K · filed 2019-03-15 | |||||
| 2018-09-30 | $672.00K 10-Q · filed 2019-11-06 | $1.36M derived: sum of 2 quarters · filed 2019-11-06 | $2.15M 10-Q · filed 2019-11-06 | -$3.08M derived: sum of 4 quarters · filed 2020-06-29 | ||||||
| 2018-06-30 | $684.00K 10-Q · filed 2019-08-07 | $1.48M 10-Q · filed 2019-08-07 | -$3.76M derived: sum of 3 quarters · filed 2020-06-29 | -$3.15M derived: sum of 4 quarters · filed 2020-06-29 | ||||||
| 2018-03-31 | $793.00K 10-Q · filed 2019-05-09 | -$4.44M derived: sum of 2 quarters · filed 2020-06-29 | -$3.84M derived: sum of 3 quarters · filed 2020-06-29 | $445.00K derived: sum of 4 quarters · filed 2020-06-29 | ||||||
| 2017-12-31 | -$5.23M derived: 8-K 12 month − 10-Q 9 month · filed 2020-06-29 | -$4.63M derived: sum of 2 quarters · filed 2020-06-29 | -$348.00K derived: sum of 3 quarters · filed 2020-06-29 | $1.42M 8-K · filed 2020-06-29 | $7.38M 10-K · filed 2018-03-16 | |||||
| 2017-09-30 | $605.00K 10-Q · filed 2018-11-07 | $4.89M derived: sum of 2 quarters · filed 2018-11-07 | $6.65M 10-Q · filed 2018-11-07 | $8.54M derived: sum of 4 quarters · filed 2019-03-15 | ||||||
| 2017-06-30 | $4.28M 10-Q · filed 2018-08-09 | $6.05M 10-Q · filed 2018-08-09 | $7.93M derived: sum of 3 quarters · filed 2019-03-15 | $9.87M derived: sum of 4 quarters · filed 2019-03-15 | ||||||
| 2017-03-31 | $1.77M 10-Q · filed 2018-05-09 | $3.65M derived: sum of 2 quarters · filed 2019-03-15 | $5.59M derived: sum of 3 quarters · filed 2019-03-15 | $5.59M derived: sum of 4 quarters · filed 2019-03-15 | ||||||
| 2016-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $3.82M derived: sum of 2 quarters · filed 2019-03-15 | $3.82M derived: sum of 3 quarters · filed 2019-03-15 | $3.82M 10-K · filed 2019-03-15 | ||||||
| 2016-09-30 | $1.93M 10-Q · filed 2017-11-13 | $1.93M derived: sum of 2 quarters · filed 2017-11-13 | $1.93M 10-Q · filed 2017-11-13 | $1.93M derived: sum of 4 quarters · filed 2018-03-16 | ||||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | $0.00 derived: sum of 4 quarters · filed 2018-03-16 | ||||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-03 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | |||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 10-K · filed 2018-03-16 | |||||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | ||||||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-01 |